Ginger Vanhoozer
Papers
1
Total Citations
58
H-Index
1
About
Ginger Vanhoozer is a leading researcher in healthcare epidemiology and infection prevention, whose work has reshaped clinical practices for controlling multidrug-resistant organisms. Her most impactful contribution is a landmark 2018 study that rigorously evaluated the safety of discontinuing contact precautions for patients with methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant *Enterococcus* (VRE). Using an interrupted time series analysis, this pivotal investigation demonstrated that removing these isolation protocols did not lead to an increase in healthcare-associated infections, directly challenging long-standing infection control dogma. This highly cited work (58 citations) has provided crucial evidence for hospitals seeking to optimize patient flow, reduce isolation-related harms, and reallocate resources without compromising patient safety. Vanhoozer’s research sits at the critical intersection of clinical epidemiology, patient-centered care, and health systems efficiency. By generating real-world evidence that supports the de-escalation of contact precautions, she has empowered institutions to move beyond one-size-fits-all isolation policies toward more nuanced, evidence-based infection prevention strategies. Her scholarship continues to influence national guidelines and serves as a model for using rigorous quasi-experimental methods to evaluate the unintended consequences of entrenched clinical practices.
Research Focus
Key Achievements
Top Papers
- 1